Skip to main content

Mesa Biotech: Ingo Chakravarty

Mesa Biotech has appointed Ingo Chakravarty as the firm's president and CEO, effective April 15. Chakravarty replaces Hong Cai, a cofounder of Mesa, who has transitioned to be the firm's chief technology officer. Chakravarty most recently served as president and CEO of Navican Genomics, and has held senior leadership positions at GenMark Diagnostics, Gen-Probe, Roche, and Ventana Medical Systems.

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.